In this study, we used the UALCAN analysis to emphasize the differential expression of DVL2 in different molecular subtypes of breast cancer and observed that DVL2 is upregulated in the breast tumor samples compared to the benign breast tissues. This evidence concerns the gene DVL2 and breast carcinoma.